A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/1992
10/21/1992	EP0509968A1 Synthetic polycarboxylates and proteins hydrogels for drug sustained release and process for the production thereof
10/21/1992	EP0509761A1 Transdermal composition containing selegiline
10/21/1992	EP0509606A1 Tableting excipient
10/21/1992	EP0509041A1 Fibrin sealant delivery method
10/21/1992	EP0506845A4 Uncharged morpholino-based polymers having achiral intersubunit linkages
10/21/1992	CN1065465A Polyethylene protein conjugates
10/20/1992	US5157104 Antitumor, anticarcinogenic agents
10/20/1992	US5157030 Adding lecithin polysorbate, glycerol monostearate, or polyether surfactant
10/20/1992	US5156847 Aporphinoid alkaloid in nonaqueous solvent
10/20/1992	US5156846 Percutaneous drug delivery system
10/20/1992	US5156840 Amine-containing porphyrin derivatives
10/20/1992	CA2065658A1 Conjugates of liposomes or microbeads and antibodies specific for t lymphocytes and their use in vivo immune modulators
10/20/1992	CA1309087C Cyclodextrin clathrates of carbacyclin derivatives and their use as medicinal agents
10/20/1992	CA1309046C Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
10/20/1992	CA1309026C Stable 5-fluorouracil compositions
10/20/1992	CA1309025C Topical preparation containing ofloxacin
10/20/1992	CA1309021C Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols as percutaneous absorption enhancers
10/20/1992	CA1309018C Prolonged release or biologically active polypeptides
10/18/1992	WO1992018108A1 Improved retard systems for delayed release of medical and/or biological valuable substances from a depot-carrier material
10/18/1992	CA2108680A1 Improved retard systems for the sustained release of medicinal and/or biological valuable materials from a depot carrier material
10/16/1992	WO1992018114A1 Nabumetone powders
10/16/1992	CA2108379A1 Nabumetone powders
10/16/1992	CA2065134A1 Transdermal composition
10/15/1992	WO1992017505A1 Monoclonal antibodies to stem cell factor receptors
10/15/1992	WO1992017436A1 Cross-linking agent
10/15/1992	WO1992017213A1 Improvements in or relating to contrast agents
10/15/1992	WO1992017210A1 Novel protein polycation conjugates
10/15/1992	WO1992017208A1 An emollient composition
10/15/1992	WO1992017207A1 MONOCLONAL ANTIBODIES WHICH BIND TO SECRETED AND MEMBRANE-BOUND IgE, BUT NOT TO IgE ON BASOPHILS
10/15/1992	WO1992017206A1 Wound healing
10/15/1992	WO1992017190A1 Dry starch-iodine pharmaceutical formulations
10/15/1992	WO1992017184A2 Bioactive topical siloxane compositions having enhanced performance and safety
10/15/1992	WO1992017167A1 Oral delivery systems for microparticles
10/15/1992	WO1992017160A1 Use of sphingolipids in the preparation of a cosmetic or dermapharmaceutical composition protecting the skin and hair against the harmful effects of atmospheric pollution
10/15/1992	WO1992007939A3 Polypeptide with 46kd hmfg differentiation antigen binding specificity
10/15/1992	CA2106065A1 Emollient composition
10/14/1992	EP0508969A1 Process for conditioning of water-soluble substances
10/14/1992	EP0508756A1 Stabilized vitamin D preparation
10/14/1992	EP0508724A1 Radiopharmaceutical bacteriostats
10/14/1992	EP0508653A1 Sustained-release pharmaceutical preparation and process for preparing the same
10/14/1992	EP0508435A2 Pharmaceutical composition of stabilized [Leu 13]-motilin-Hse
10/14/1992	EP0508311A1 Injectable compositions containing 2-oxindole-1-carboxamide derivatives
10/14/1992	EP0508310A1 Pharmaceutical composition for rectal administration, which contains a 2-oxindole-1-carboxamide derivative
10/14/1992	EP0508194A1 Stabilized factor VIII preparations
10/14/1992	EP0507944A1 Implantable biodegradable material and method for producing same.
10/14/1992	EP0500802A4 Liposomal compositions
10/14/1992	EP0368933B1 Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloalkanes
10/14/1992	CN1018649B Immunoglobulin conjugates
10/13/1992	US5155246 Wool-wax substitutes
10/13/1992	US5155210 Produce localized cytotoxic effects on target cells; antitumor and anticarcinogenic agents
10/13/1992	US5154930 Pharmacological agent-lipid solution preparation
10/13/1992	US5154926 Acetaminophen or phenobarbital syrup composition
10/13/1992	US5154924 Method for delivering a neuropharmaceutical agent across the blood brain barrier to the brain of a host
10/13/1992	US5154922 Compositions for transdermal delivery of estradiol
10/13/1992	US5154853 Alkylating branches of multi-branch core alkyl compound with alkyne building lbock having ether side chains; reducing; deprotecting; functionalizing
10/13/1992	CA1308838C Elastomeric silicone polyaddition composition comprising iodine
10/13/1992	CA1308837C Elastomeric silicone polyaddition composition comprising iodine
10/13/1992	CA1308836C Hot vulcanisable silicone elastomer based composition containing iodine
10/13/1992	CA1308662C Spray dried acetaminophen
10/11/1992	WO1992018098A1 Antimicrobial compositions useful for medical applications
10/11/1992	CA2065530A1 Saliva substitute
10/09/1992	WO1992017166A1 Capsule
10/09/1992	CA2107678A1 Capsule
10/09/1992	CA2064150A1 Sustained release pharmaceutical preparation and process for preparing the same
10/07/1992	EP0507598A1 Sweetening agents
10/07/1992	EP0507573A2 Readily absorbable motilin preparations
10/07/1992	EP0507484A1 A pharmaceutical formulation of aureobasidins
10/07/1992	EP0507224A2 Use of combinations of gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
10/07/1992	EP0507047A2 Emulsifiers for preparing oil-in-water emulsions of etheric oils useful for cosmetic on medical purposes
10/07/1992	EP0506979A1 Organic polymer compound and production thereof
10/07/1992	EP0506976A1 Combination of hyaluronic acid with medicinal ingredient and production thereof
10/07/1992	EP0506845A1 Uncharged morpholino-based polymers having achiral intersubunit linkages
10/07/1992	EP0506844A1 Sustained flavorant release composition, method for making same and chewable structure incorporating same
10/07/1992	EP0506792A1 Insulin preparations containing nicotinic acid or nicotinamide.
10/07/1992	EP0506774A1 Smoking substitute.
10/06/1992	USRE34091 Sialic acid derivatives having active carbonyl group
10/06/1992	US5153319 Process for preparing polynucleotides
10/06/1992	US5153312 Respiratory system disorders
10/06/1992	US5153265 Conjugation of polymer to colony stimulating factor-1
10/06/1992	US5153221 Method for the treatment of acquired immune deficiency syndrome
10/06/1992	US5153179 Medicament with improved penetration of the tissue membrane
10/06/1992	US5153125 Process for producing lysophospholipids-containing phospholipids with reduced neutral lipid content
10/06/1992	US5153118 Monoclonal antibodies having binding specificity to human prostate tumor-associated antigens and methods for employing the same
10/06/1992	US5152991 Use of selectively hydrogenated styrene/butadiene copolymers in cosmetic and pharmaceutical compositions
10/06/1992	US5152986 Preparation and use of ion exchange resins loaded with quinolonecarboxylic acid derivatives
10/06/1992	US5152980 Suppression of immune response by administering interleukin-toxin hybrid molecule or anti-interleukin receptor antibody
10/06/1992	CA2065065A1 Sweetening agents
10/06/1992	CA1308377C Complex of polyethyleneglycol and tissue plasminogen activator
10/06/1992	CA1308358C Antibacterial lyophilized preparation
10/06/1992	CA1308357C Method for the preparation of a coated solid medicament
10/06/1992	CA1308353C Preparation of solid pharmaceutical forms
10/06/1992	CA1308352C Compositions comprising 1-oxohydrocarbyl-substituted azacyclohexanes
10/05/1992	WO1992017164A1 Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress
10/05/1992	WO1992017161A1 Chewable antacid compositions
10/03/1992	WO1992017216A1 Delivery of x-ray contrast agents using receptor mediated endocytosis
10/03/1992	CA2105068A1 Delivery of x-ray contrast agents using receptor mediated endocytosis
10/03/1992	CA2064637A1 Method and catheter for controlled intravascular drug delivery
10/03/1992	CA2063968A1 Pharmaceutical formulation of aureobasidins
10/01/1992	WO1992016660A1 Methods for detection and treatment of cancer
10/01/1992	WO1992016484A1 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity

1 ... 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 1627 ... 1712